期刊文献+

GPNMB基因纯合变异导致色素异常性皮肤淀粉样变性一家系 被引量:3

Amyloidosis cutis dyschromica due to homozygous variants of the GPNMB gene in a pedigree
原文传递
导出
摘要 目的对1个色素异常性皮肤淀粉样变性家系的3例患者的GPNMB基因进行变异分析,明确其致病原因。方法对先证者行高通量测序,采用生物信息学方法寻找致病基因变异,并通过Sanger测序对家系内成员是否携带变异进行验证。结果先证者及其哥哥、妹妹GPNMB基因的第5外显子均存在c.565C>T(p.Arg189X)纯合无义变异,其变异后蛋白发生截短进而蛋白功能丧失。父亲携带c.565C>T(p.Arg189X)杂合变异,母亲因死亡无法验证。根据美国医学遗传学与基因组学学会遗传变异分类标准与指南,c.565C>T变异为可能致病性变异(PS3+PM2+PP1+PP3)。结论GPNMB基因第5外显子c.565C>T(p.Arg189X)纯合变异可能为该色素异常性皮肤淀粉样变性家系患者的致病原因,新变异的检出拓宽了GPNMB基因的变异谱。 Objective To explore the genetic basis for a Chinese pedigree affected with amyloidosis cutis dyschromica.Methods High throughput sequencing was carried out for the proband.Bioinformatic analysis was used to identify the pathogenic variants.The result was verified by Sanger sequencing.Results A homozygous nonsense variant c.565C>T(p.Arg189X)of the GPNMB gene was identified in the proband,his elder brother and younger sister,which resulted a truncated protein with loss of function.The father of the proband was a heterozygous carrier.The genotype of his mother was unknown since she had passed away.Based on the American College of Medical Genetics and Genomics standards and guidelines,the c.565C>T variant was predicted to be likely pathogenic(PS3+PM2+PP1+PP3).Conclusion The novel homozygous GPNMB variant probably underlay the amyloidosis cutis dyschromica in this pedigree.Above finding has expanded the variant spectrum of the GPNMB gene.
作者 沙艳伟 李琳 Sha Yanwei;Li Lin(Women and Children’s Hospital,School of Medicine,Xiamen University,Xiamen,Fujian 361003,China;Central Laboratory,Beijing Obstetrics and Gynecology Hospital,Capital Medical University,Beijing 100026,China)
出处 《中华医学遗传学杂志》 CAS CSCD 2021年第2期123-126,共4页 Chinese Journal of Medical Genetics
基金 国家自然科学基金(81871200)。
关键词 色素异常性皮肤淀粉样变性 GPNMB基因 高通量测序 Amyloidosis cutis dyschromica GPNMB gene Whole-exome sequencing
  • 相关文献

参考文献2

二级参考文献18

  • 1I.ee I)D, l.in MW, Chen IC, el al. Genome-wide scan identifies a susceptibility locus for familial primary cutaneous amyloidosis on chromosome 5p13.1-qll. 2. Br J Dermatol,2006,155:1201-1208.
  • 2Arita K,South AP, Hans-Filho G,el al. Oncostatin M receptor- hera mutations underlie familial primary localized cutaneous amyloidosis. Am J H um Genet, 2008,82 : 73-80.
  • 3l.in MW,I.ee DD,I.iu TT,et al. Novel IL31RA gene mutation and ancestral OSMR mutant allele in familial primary cutaneous amyloidosis. Eur J Hum Genet,2010,18:26-32.
  • 4Heinrich PC,Behrmann 1, Haan S, et al. Principles of interleukin (IL) 6-type cytokine signalling and its regulation. Biochem J, 2003,374:1 20.
  • 5Boniface K,Diveu C,Morel F,et al. Oncostatin M secrmed hyskin infiltrating T lymphocytes is a potent keratinocyte activator involved in skin inflammation. J Immunol,2007,178:4615-4622.
  • 6Arita K,Abe R,Baba K,et al. A novel OSMR mutation in familial primary localized cutaneous amyloidosis in a Japanese family. J Dermatol Sci,2009,55:64-65.
  • 7Grosshans E,Bergoend H,Khochnevis A.erblichen Haut-Amyloidosen[J].Munch Wochenschr,1972,114:1183-1190.
  • 8Morishima T.A clinical variety of localized cutaneousamyloidosis characterized by dyschromia(amyloidosis cu-tis dyschromica)[J].Jpn J Dermatol,1970,80:43-52.
  • 9Eng AM,Cogan L,Gunnar RM,et al.Familial generalizeddyschromic amyloidosis cutis[J].J Cutan Pathol,1976,3(2):102-108.
  • 10Huang WH,Wu CY,Yu CP,et al.Amyloidosis cutis dys-chromica:four cases from two families[J].Int J Derma-tol,2009,48(5):518-521.

共引文献5

同被引文献17

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部